Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences High-Value Diagnostics

High-Value Diagnostics

Date: Monday, 16 November 2015 - Tuesday, 17 November 2015
Location: Boston, USA


Keynote Speakers

Kendall Van Keuren-Jensen

Kendall Van Keuren-Jensen
Associate Professor, Translational Genomics Research Institute

David Wong

David Wong
Felix and Mildred Yip Endowed Chair in Dentistry; Director for UCLA Center for Oral/Head & Neck Oncology Research, University of California-Los Angeles

Ellen Beasley

Ellen Beasley
Senior Vice President, Genomic Health Inc

Lawrence Rajendran

Lawrence Rajendran
Velux Stiftung Professor for Systems and Cell Biology of Neurodegeneration, University of Zurich

Xandra Breakefield

Xandra Breakefield
Professor, Mass General Hospital (MGH)/Harvard Medical School

Dominique PV de Kleijn

Dominique PV de Kleijn
Professor Experimental Vascular Surgery, Professor Netherlands Heart Institute, University Medical Center Utrecht, The Netherlands

Raghu Kalluri

Raghu Kalluri
Professor & Chairman, Department of Cancer Biology; Olla S. Stribling Distinguished Chair for Cancer Research, MD Anderson Cancer Center

Walter Koch

Walter Koch
Vice President, Roche Molecular Systems

Lynn Sorbara

Lynn Sorbara
Program Director, National Cancer Institute

Overview

The 2nd Annual Biofluid Biopsies and High Value Diagnostics 2015 Conference brings together academic researchers, industry researchers, as well as biotechnology and pharmaceutical companies to explore the expanding and evolving field whereby Circulating Biomarkers of various classes are being evaluated for their potential to be developed into diagnostics for cancer as well as other disease classes.

The Biofluid Biopsies Conference Track focuses primarily on biofluid-based molecular biomarkers, such as circulating tumor DNA (ctDNA) as well as circulating tumor cells (CTCs), and protein-based circulating biomarkers.  There is much interest in the potential of ctDNA for developing biological fluid-based biopsies (such as using plasma, urine, or other biofluids) and the presenters in this track bring together the most up-to-date information and current state-of-the-field.

The High-Value Diagnostics Conference Track explores the potential of various minimally-invasive circulating biomarker classes, such as circulating-free DNA (cfDNA), CTCs, and Extracellular Vesicles (EVs), for development of novel diagnostics for patient monitoring and precision/targeted medicine.

We also explore the front-end sample preparation challenges and approaches for the deployment of various biofluid classes (plasma, serum, urine, cerebrospinal fluid, ovarian follicular fluid, and saliva) into diagnostics development in both the conference tracks.

All conference delegates receive access to both concurrent, co-located conference tracks enabling maximal learning and maximizing networking opportunities.

Present Your Research at this Conference in a Poster to a Worldwide Audience.  Poster Submission Deadline:  November 2, 2015

Agenda Topics

  • Circulating Tumor Cells (CTCs): Potential for Development of Biofluid-based Biopsies
  • Circulating Tumor DNA (ctDNA): Potential for Development of Biofluid-based Biopsies
  • Extracellular Nucleic Acids in the Circulation: Circulating Free DNA, Extracellular RNA and Their Use to Develop Diagnostics
  • Extracellular Vesicles (EVs): Potential for Development of Biofluid-based Biopsies
  • Potential of microRNAs as Biomarkers for Diagnostics Development and as Companion Diagnostics
  • US vs. EU vs. Asia/Pacific Regulatory Landscape for Novel High-Value Diagnostics

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865

Confirmed Speakers to date

Lyle Arnold, Chief Scientific Officer, Biocept
Dolores Di Vizio, Professor, Cedars Sinai Medical Center
Sandra Gaston, Director, Molecular Biomarkers Research Laboratory; Scientific Director, Tufts Medical Center Biorepository, Tufts Medical Center
Yousef Haj-Ahmad, President & CEO, Norgen Biotek Corp
Malini Harigopal, Associate Professor, Dept of Pathology, Breast and Cytopathology, Yale University
Tim Harkins, President and CEO, Swift Biosciences
Ruth Katz, Professor of Pathology, Chief Image Analysis Laboratory, Chief Research Cytopathology, MD Anderson Cancer Center
Shlomit Kenigsberg, Senior Researcher, Create Fertility Centre
Winston Patrick Kuo, SAB, Exosomics Siena; Editor-in-Chief, Journal of Circulating Biomarkers, InTech Publishers
Bernard Lam, Senior Research Scientist, Norgen Biotek Corporation
Louise Laurent, Associate Professor, University of California-San Diego
Clifford Librach, Medical and Scientific Director, CReATe Fertility Centre
Y. Peng Loh, Chief and Senior Investigator, Section on Cellular Neurobiology, Eunice Kennedy Shriver National Institute of Child health and Human Development, National Institutes of Health (NIH)
Klaus L├╝cke, CEO & Founder, GILUPI GmbH
Susan Magdaleno, Sr. Manager, R&D, Thermo Fisher Scientific
Mike Makrigiorgos, Professor, Dana-Farber Cancer Institute/Harvard Medical School
Roy Overton, VP, Laboratory Operations, CytoVas, LLC
Cloud Paweletz, Head of the Translational Research Laboratory, Dana Farber Cancer Institute
Johan Skog, Chief Scientific Officer, Exosome Diagnostics Inc
Theresa Zhang, Vice President, Research Services, Personal Genome Diagnostics

All Delegates, Speakers, and Exhibitors Receive as Part of the Conference Materials Package, access to the Conference Cloud Loaded with the Most Up-to-Date Publications/Articles, PowerPoint Presentations, and Review Articles focusing on the Biofluid Biopsies field--this includes publications/reviews/presentations on CTCs, Circulating DNA/RNA, as well as Extracellular Vesicles (EVs).  Excellent to Bring Back to the Office and Use as Reference Materials for Publications, R&D Presentations, Business Plans, and User Manuals.


Corporate Sponsors Media Sponsors Networking
U-Networks

Add to Calendar ▼2015-11-16 00:00:002015-11-17 00:00:00Europe/LondonHigh-Value DiagnosticsSELECTBIOenquiries@selectbiosciences.com